Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FCMI Financial is a private investment firm based in Toronto, Canada, serving as the primary investment vehicle for the Friedberg family. The company is a prominent investor in the life sciences and biotechnology sectors, often taking significant or controlling equity positions in clinical-stage entities. FCMI is particularly known for its long-term support of Aptose Biosciences, focusing on the development of targeted oncology therapies. The firm also maintains a diverse portfolio that includes investments in neuroscience and drug delivery technologies through companies like Chronos Therapeutics and Ichor Medical Systems. By providing strategic capital and oversight, FCMI Financial assists its portfolio companies in navigating the complex drug development and regulatory landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FCMI Financial.